Who owns ENANTA PHARMACEUTICALS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ENTA from SEC Form 13F filings across 129 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 129 institutions disclosed 26.5M shares of ENANTA PHARMACEUTICALS INC worth $349.5M — about 91.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
129
13F holders
$349.5M
value, 2026 filers
91.5%
of shares outstanding (26.5M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ENTA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.9M | $51.2M | 0.0% | 13.4% | +19.7% |
| 2 | Janus Henderson Group Ltd.NEW | 3.7M | $48.2M | 0.0% | 12.6% | new |
| 3 | Krensavage Asset Management, LLC | 2.9M | $37.8M | 14.2% | 9.9% | 0.0% |
| 4 | ADAR1 Capital Management, LLC | 1.7M | $22.8M | 1.0% | 6% | +28.9% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $15.8M | 0.0% | 4.1% | -1.3% |
| 6 | Spruce Street Capital LP | 1.1M | $14.3M | 2.3% | 3.8% | 0.0% |
| 7 | ACADIAN ASSET MANAGEMENT LLC | 1.0M | $13.4M | 0.0% | 3.5% | -5.3% |
| 8 | Deep Track Capital, LP | 1.0M | $13.2M | 0.2% | 3.4% | -30.8% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 976,693 | $12.9M | 0.0% | 3.4% | -3.4% |
| 10 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 950,000 | $12.5M | 0.1% | 3.3% | -60.7% |
| 11 | MILLENNIUM MANAGEMENT LLC | 774,748 | $10.2M | 0.0% | 2.7% | +20.3% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 634,594 | $8.4M | 0.0% | 2.2% | -18.3% |
| 13 | STATE STREET CORP | 573,922 | $7.6M | 0.0% | 2% | -0.4% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 473,000 | $6.2M | 0.0% | 1.6% | -15.2% |
| 15 | Hillsdale Investment Management Inc. | 437,500 | $5.8M | 0.1% | 1.5% | -6.5% |
| 16 | GOLDMAN SACHS GROUP INC | 428,562 | $5.6M | 0.0% | 1.5% | -7.8% |
| 17 | MORGAN STANLEY | 380,070 | $5.0M | 0.0% | 1.3% | +20.4% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 308,077 | $4.1M | 0.0% | 1.1% | +2.3% |
| 19 | DIMENSIONAL FUND ADVISORS LP | 291,226 | $3.8M | 0.0% | 1% | +3.0% |
| 20 | SummitTX Capital, L.P.NEW | 261,289 | $3.4M | 0.1% | 0.9% | new |
| 21 | NORTHERN TRUST CORP | 255,847 | $3.4M | 0.0% | 0.9% | -1.5% |
| 22 | AQR CAPITAL MANAGEMENT LLC | 233,232 | $3.1M | 0.0% | 0.8% | -9.2% |
| 23 | Longaeva Partners L.P.NEW | 226,587 | $3.0M | 0.1% | 0.8% | new |
| 24 | Connor, Clark & Lunn Investment Management Ltd. | 189,993 | $2.5M | 0.0% | 0.7% | +24.2% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 180,244 | $2.4M | 0.0% | 0.6% | -2.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.